Sandoz is planned to be incorporated in Switzerland and to be listed on the SIX Swiss Exchange, with an American Depositary Receipt (ADR) program in the US
Biopharma and CROs to benefit from simplified access to global research sites
The company now exceeds the sector benchmark for its overall ESG rating and for all three measures
Medicines, including insulin, to be available in 40 lower-income countries
Condon joins DTx Pharma with more than 20 years of experience in business development, commercial planning, and operations.
Ganguly will execute company's strategic focus on leveraging CustomGlycan to develop novel therapeutics
Futnani has over two decades of experience in delivering growth and transformation that spans several therapeutic areas.
Turn has developed a novel cell rejuvenating platform with significant potential for application in an array of age-related diseases
Daewoong Pharmaceutical, HanAll Biopharma join Astellas Venture Management and other VCs in oversubscribed funding round to accelerate Turn Bio's preclinical advances in multiple therapeutic areas
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
